On RemeGen (688331.SH/09995.HK) announced that the results of the Phase III clinical study of Telitacicept for Sjögren's Syndrome in China have been published in an abstract on the 2025 ACR website.

The authors describe an interesting approach to studying the dynamics and function of membrane proteins in different lipid environments. The important findings have theoretical and practical ...

AlphaFold 3 (AF3), the latest AI model from Google DeepMind and Isomorphic Labs, can predict the structures and interactions ...

The rapid advancement of artificial intelligence (AI) is transforming the field of structural biology. In May 2024, DeepMind and Isomorphic Labs launched AlphaFold 3 (AF3), a revolutionary AI system ...

Discover how integrating artificial intelligence with biophysical methods enables the identification of novel BRPF1b ...

A landmark study published in Experimental Neurology demonstrates that Polku Therapeutics' proprietary prolyl oligopeptidase (PREP) ligand prevents long-term memory impairment in a model of repeated ...

China: Telitacicept significantly reduced proteinuria in patients with IgA nephropathy, while maintaining an acceptable ...

Researchers have identified two experimental medications that may be able to promote myelin repair in people with MS, a study ...

PagePeek revolutionizes paper assessment in molecular dynamics through AI-driven validation, ensuring reproducibility, ...

New evidence is elucidating the apparent link between gut microbiota and idiopathic pulmonary fibrosis (IPF), which may be mediated by circulating inflammatory proteins. The study, which was published ...

From bispecific engineering to clinically relevant data sourcing, evolving antibody technologies advance oncology therapeutics.

Frizzled (FZD) proteins are the principal receptors of the Wnt signaling pathway. However, whether Wnt ligands induce FZD endocytosis and degradation remains elusive. The transmembrane E3 ubiquitin ...